UNSPSC 85522914: Supplement upper vein with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement upper vein with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05UY37Z

UNSPSC 85522914 Supplement upper vein with autologous tissue substitute, percutaneous approach is a Commodity code that describes a specific surgical procedure involving vascular grafting. However, the recent state and local contract opportunities posted under this code show no activity aligned with the procedure itself. Instead, the opportunities span occupational medical surveillance, independent medical evaluations for disability pension determinations, pharmacy benefit management, temporary health professional staffing, surgical procedure carve-out benefits for municipal employees, and specialty medical services for detained youth. These solicitations represent administrative health services, benefits management, and clinical staffing — none of which involve vascular surgical procedures. The issuing bodies include state departments (Washington State Department of Transportation), counties (Harris County, Santa Clara County, Collier County), and cities (Phoenix, Long Beach), suggesting this code may be mis-tagged across multiple jurisdictions or the UNSPSC designation does not accurately reflect the medical-administrative and staffing services being procured.

The code shows no relevant recent activity for the vascular procedure it nominally describes. Representative recent opportunities include the Washington State Department of Transportation's RFP for occupational medical surveillance services (due October 9, 2026), the City of Phoenix Retirement Office's RFP for independent medical evaluation services supporting disability benefit determinations (due October 16, 2026 with a maximum contract value of $750,000 over five years), and the City of Long Beach's RFP for a surgical procedure carve-out benefit program managing pre- and post-care for orthopedic, cardiac, and oncology procedures (due October 7, 2026). Activity appears concentrated in California, Arizona, and Washington, with additional opportunities in Florida and Texas. Given the mismatch between the code's procedural scope and the administrative and staffing services actually being solicited, this code does not represent a reliable procurement indicator for vascular surgery services in the state and local market.